Back to Results
First PageMeta Content
Health / Acetamides / Influenza A virus subtype H1N1 / Guanidines / Vaccines / Oseltamivir / Flu pandemic / Zanamivir / Pandemic H1N1/09 virus / Influenza / Neuraminidase inhibitors / Chemistry


RAPID RISK ASSESSMENT Oseltamivir-resistant influenza A(H1N1)2009 cluster in Australia September 2011
Add to Reading List

Document Date: 2013-12-02 16:31:25

Open Document

File Size: 622,25 KB

Share Result on Facebook

City

Geneva / Perth / Brisbane / Sydney / Stockholm / Newcastle / /

Company

Reference Laboratories / Wertheim HF / /

Continent

Europe / /

Country

Netherlands / South Africa / Norway / France / United States / Australia / United Kingdom / Scotland / Denmark / /

/

Facility

centre of Newcastle / WHO Collaborating Centre / /

MedicalCondition

oseltamivir-resistant influenza viruses / A(H1N1) influenza / severe influenza / influenza virus / influenza / H1N1 influenza / subsequent southern hemisphere influenza / Disease / NAIs targeting influenza / seasonal influenza / influenza virus neuraminidase inhibitors / virus infection / influenza viruses / A(H1N1) influenza viruses / severe influenza-related illness / recommended seasonal flu / Infectious Diseases / Weekly influenza / influenza B / /

MedicalTreatment

vaccination / immunosuppression / /

Organization

World Health Organization / World Health Organization Collaborating Centre / European Centre for Disease Prevention and Control / WHO Collaborating Centre / European Union / /

Person

Charles Penn / Anne Kelso / Sylvie Briand / Rod Daniels / Adam Meijer / /

Position

Governor / Hunter / /

ProvinceOrState

Western Australia / Queensland / New South Wales / North Carolina / New / /

Region

South East Asia / Oceania / South Wales / Asia-Pacific / Western Australia / /

Technology

pdf / /

URL

http /

SocialTag